Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-01-14, Stock:ABBV, The news for the past five days is as follows:
2019-01-07: NEWS1: AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know.NEWS2: Peninsula Alzheimer's fighter hunts $150 million IPO.NEWS3: Neurocrine Gives Ingrezza Sales View, Updates on Pipeline.NEWS4: Neurocrine Gives Ingrezza Sales View, Updates on Pipeline.NEWS5: Neurocrine Gives Ingrezza Sales View, Updates on Pipeline.NEWS6: Neurocrine Biosciences Is a Pharma Stock to Watch.NEWS7: Neurocrine Biosciences Is a Pharma Stock to Watch.NEWS8: Notable ETF Inflow Detected - SDY, T, O, ABBV.NEWS9: Notable ETF Inflow Detected - SDY, T, O, ABBV.NEWS10: As Patent Expirations Loom, the Clock Is Ticking on AbbVie Stock.NEWS11: Gilead (GILD) Collaborates With Yuhan for NASH Candidates.NEWS12: Gilead (GILD) Collaborates With Yuhan for NASH Candidates.NEWS13: Gilead (GILD) Collaborates With Yuhan for NASH Candidates.NEWS14: Jim Cramer Gives His Opinion On Ciena, Momo, Qualcomm And More.NEWS15: Neurocrine Biosciences Is a Pharma Stock to Watch.NEWS16: Today's Research Reports on Trending Tickers: AbbVie and Allergan.NEWS17: The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Merck, Pfizer and AbbVie.NEWS18: The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Merck, Pfizer and AbbVie.NEWS19: The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Merck, Pfizer and AbbVie.NEWS20: 3 Bargain Stocks You Can Buy Right Now.NEWS21: 3 Bargain Stocks You Can Buy Right Now.
2019-01-08: NEWS1: Top Analyst Reports for Visa, Coca-Cola & AbbVie.NEWS2: AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know.NEWS3: AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know.
2019-01-09: NEWS1: AbbVie Falls 3%.NEWS2: Novartis' Crizanlizumab Gets Breakthrough Therapy Status.NEWS3: Novartis' Crizanlizumab Gets Breakthrough Therapy Status.NEWS4: The Zacks Analyst Blog Highlights: Visa, Coca-Cola, AbbVie, Johnson & Johnson and Duke Energy.NEWS5: The Zacks Analyst Blog Highlights: Visa, Coca-Cola, AbbVie, Johnson & Johnson and Duke Energy.NEWS6: Is AbbVie (ABBV) a Great Value Stock Right Now?.NEWS7: Is AbbVie (ABBV) a Great Value Stock Right Now?.NEWS8: Is AbbVie (ABBV) a Great Value Stock Right Now?.NEWS9: The Zacks Analyst Blog Highlights: Visa, Coca-Cola, AbbVie, Johnson & Johnson and Duke Energy.NEWS10: Novartis' Crizanlizumab Gets Breakthrough Therapy Status.NEWS11: See what the IHS Markit Score report has to say about AbbVie Inc..NEWS12: Inside look: LNG bunker that puts Jaxport on world map.NEWS13: Top Picks 2019- AbbVie Inc. ABBV.
2019-01-10: NEWS1: 6 High-Cap Stocks Paying High Dividend Yields.NEWS2: 3 Big Reasons Why AbbVie Isn't Worried About Humira.NEWS3: 3 Big Reasons Why AbbVie Isn't Worried About Humira.NEWS4: 3 Dividend Stocks That Pay You Better Than Coca-Cola Does.NEWS5: 3 Dividend Stocks That Pay You Better Than Coca-Cola Does.NEWS6: Ex-Dividend Reminder: Publix Super Markets, AbbVie and Quest Diagnostics.NEWS7: Ex-Dividend Reminder: Publix Super Markets, AbbVie and Quest Diagnostics.NEWS8: Top Ranked Momentum Stocks to Buy for January 10th.NEWS9: Top Ranked Momentum Stocks to Buy for January 10th.NEWS10: 3 Dividend Stocks That Pay You Better Than Coca-Cola Does.NEWS11: 3 Big Reasons Why AbbVie Isn&apos;t Worried About Humira.NEWS12: Top Ranked Momentum Stocks to Buy for January 10th.
2019-01-11: NEWS1: 5 Reasons Why Investors Should Buy Novo Nordisk (NVO) in 2019.NEWS2: Noteworthy Friday Option Activity: TSLA, THS, ABBV.NEWS3: Noteworthy Friday Option Activity: TSLA, THS, ABBV.NEWS4: 3 Back-of-the-Shelf Consumer Stocks With Growth and Income.NEWS5: Top Ranked Momentum Stocks to Buy for January 11th.NEWS6: Top Ranked Momentum Stocks to Buy for January 11th.NEWS7: Top Ranked Momentum Stocks to Buy for January 11th.NEWS8: Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet.NEWS9: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for January 14, 2019.NEWS10: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for January 14, 2019.NEWS11: The Implied Analyst 12-Month Target For FTC.NEWS12: The Implied Analyst 12-Month Target For FTC.NEWS13: [$$] Senator Collins Presses HHS to Reform Drug Rebate System.

Answer: Decrease